N-NITROSO-DALBAVANCIN B0
UNII A85CF8V7PD

Substance Identification & Data

This profile provides standardized clinical and technical data for N-nitroso-dalbavancin B0, uniquely identified by the FDA Unique Ingredient Identifier (UNII) A85CF8V7PD.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

A85CF8V7PD

CAS Registry Number

N/A

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

N-NITROSO-DALBAVANCIN B0

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C88H99Cl2N11O29

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

ATWWLARXOGKNHU-BTODNKRBSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

176480812

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

[C@H]12NC([C@H](NC([C@@H]3NC([C@@H]4c5c(c(O)cc(Oc6cc([C@H](C(N[C@@H](C(N4)=O)Cc7ccc(Oc8cc3cc(c8O[C@H]9[C@@]([C@H]([C@H](O)[C@H](O9)C(=O)O)O)(NC(=O)CCCCCCCCC(C)C)[H])Oc%10ccc([C@H]1O)cc%10Cl)cc7)=O)N(C)N=O)ccc6O)c5)Cl)=O)=O)c%11cc(-c%12c([C@H](NC2=O)C(=O)NCCCN(C)C)cc(cc%12O[C@@H]%13[C@H]([C@H]([C@H](O)[C@H](O%13)CO)O)O)O)c(O)cc%11)=O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for N-nitroso-dalbavancin B0. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

N-NITROSO-DALBAVANCIN B0

Systematic Nomenclature

(2S,3S,4R,5R,6S)-6-(((1S,2R,19R,22R,33S,36R,39R,51S)-5,31-DICHLORO-51-(3-(DIMETHYLAMINO)PROPYLCARBAMOYL)-2,25,30,43,48-PENTAHYDROXY-22-(METHYL(NITROSO)AMINO)-21,34,37,53,55,58-HEXAOXO-46-((2R,3S,4S,5S,6R)-3,4,5-TRIHYDROXY-6-(HYDROXYMETHYL)OXAN-2-YL)OXY-7,13,27-TRIOXA-20,35,38,52,54,57-HEXAZAUNDECACYCLO(37.14.2.23,6.214,17.219,33.223,26.18,12.128,32.140,44.010,36.045,50)HEXAHEXACONTA-3,5,8,10,12(64),14(63),15,17(62),23,25,28(59),29,31,40(56),41,43,45(50),46,48,60,65-HENICOSAEN-64-YL)OXY)-3,4-DIHYDROXY-5-(10-METHYLUNDECANOYLAMINO)OXANE-2-CARBOXYLIC ACID

SYS

External Clinical & Regulatory Resources

Previous UNIIA8581Y0K6K

Next UNIIA85E8KM8J6